Evidence map›Paper›PMID 38992213›Full record

ArticleMolecular neurobiology2025

Neuroaxonal Injury May Mediate the Association Between Hyperglycemia and Prognosis in Spontaneous Subarachnoid Hemorrhage.

Daniel Santana, Laura Llull, Alejandra Mosteiro, Leire Pedrosa, Gabriel Pujol, Luigi Zattera, Mariano Werner, Abraham Martín, Carles Justicia, Ángel Chamorro and 2 more

Abstract read
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Daniel SantanaInstitute of Neuroscience, Comprehensive Stroke Center, Hospital Clinic of Barcelona; University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7605-322X
Laura LlullInstitute of Neuroscience, Comprehensive Stroke Center, Hospital Clinic of Barcelona; University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1464-2237
Alejandra MosteiroInstitute of Neuroscience, Neurosurgery Department, Hospital Clinic of Barcelona; University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-7170-0635
Leire PedrosaInstitut d'Investigacions Biomèdiques Agustí Pi I Sunyer (IDIBAPS), Barcelona, Spain.ORCID http://orcid.org/0000-0002-1852-4975
Gabriel PujolNeuroanesthesia Division, Anesthesiology Department, Hospital Clinic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-4757-2893
Luigi ZatteraNeurocritical Care Division, Anthesiology Department, Hospital Clinic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0001-8967-8472
Mariano WernerInstitute of Diagnostic Imaging, Interventional Neurorradiology Department, Hospital Clinic of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-1746-3226
Abraham MartínAchucarro Basque Center for Neuroscience, Leioa, Spain.ORCID http://orcid.org/0000-0002-5357-4935
Carles JusticiaInstituto de Investigaciones Biomédicas de Barcelona (IIBB), Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain.ORCID http://orcid.org/0000-0003-0969-6158
Ángel ChamorroInstitute of Neuroscience, Comprehensive Stroke Center, Hospital Clinic of Barcelona; University of Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0003-0493-5340
Ramón TornéInstitute of Neuroscience, Neurosurgery Department, Hospital Clinic of Barcelona; University of Barcelona, Barcelona, Spain. torne@clinic.cat.ORCID http://orcid.org/0000-0001-7932-2528
Sergio AmaroInstitute of Neuroscience, Comprehensive Stroke Center, Hospital Clinic of Barcelona; University of Barcelona, Barcelona, Spain. samaro@clinic.cat.ORCID http://orcid.org/0000-0001-6838-6390

Funding

Fundació la Marató de TV3 17/C/2017Hospital Clínic of Barcelona Emili Letang-Josep Font research grantsInstituto de Salud Carlos III PI19/00936
6 · The paper itself

Abstract

Hyperglycemia during early brain injury (EBI) period after spontaneous subarachnoid hemorrhage (SAH) is associated with poor outcome, but the underlying physiopathology is unknown. This study assessed if hyperglycemia during EBI is associated with markers of neuroaxonal injury and whether these biomarkers partially account for the association between hyperglycemia and poor clinical outcome. Ninety-two SAH patients admitted within 24 h of bleeding onset were prospectively included. Glucose levels were measured at arrival and every 6 h for 72 h. Serum neurofilament light chain (NFL) levels were measured at 72 h. Functional outcome was assessed with the modified Rankin Scale (mRS) at 90 days (poor outcome, mRS > 2). The association between glucose metrics, NFL levels, and clinical outcome was assessed with univariate and multivariate analyses. Mediation analysis was performed to examine the potential chain in which NFL may mediate the relationship between glucose and functional outcome. Higher glucose and NFL levels during EBI were associated with poor clinical outcome in adjusted analysis. NFL levels were associated with older age, higher initial severity, and higher glucose levels during EBI period. In adjusted mediation analyses, the association between glucose and clinical outcome was significantly mediated by NFL levels. The mediator NFL explained 25% of the association between glucose during EBI period and poor functional outcome at 90 days. In SAH, the association between glucose levels during EBI and poor clinical outcome might be significantly mediated by NFL levels. The link between hyperglycemia and poor clinical outcome might be explained in part through secondary neuroaxonal injury.

Indexed as

AxonsHyperglycemiaSubarachnoid HemorrhageAdultAgedBiomarkersBlood GlucoseFemaleHumansMaleMiddle AgedNeurofilament ProteinsPrognosisBiomarkersBlood Glucoseneurofilament protein LNeurofilament ProteinsEarly brain injuryGlucoseMediation analysisNeuroaxonal damageNeurofilamentSubarachnoid hemorrhage

Identifiers

PMID38992213
PMCPMC11772382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.